These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9015792)

  • 1. Nitric oxide and atherosclerosis: possible implications for therapy.
    Bult H
    Mol Med Today; 1996 Dec; 2(12):510-8. PubMed ID: 9015792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide function in atherosclerosis.
    Matthys KE; Bult H
    Mediators Inflamm; 1997; 6(1):3-21. PubMed ID: 18472828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary endothelial dysfunction: atherosclerosis.
    Shimokawa H
    J Mol Cell Cardiol; 1999 Jan; 31(1):23-37. PubMed ID: 10072713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endothelial dysfunction in atherosclerosis.
    Davignon J; Ganz P
    Circulation; 2004 Jun; 109(23 Suppl 1):III27-32. PubMed ID: 15198963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis: implications for impaired vasomotion.
    Harrison DG; Ohara Y
    Am J Cardiol; 1995 Feb; 75(6):75B-81B. PubMed ID: 7863980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction in atherosclerosis.
    Harrison DG
    Basic Res Cardiol; 1994; 89 Suppl 1():87-102. PubMed ID: 7945179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vascular biology of nitric oxide and its role in atherogenesis.
    Lloyd-Jones DM; Bloch KD
    Annu Rev Med; 1996; 47():365-75. PubMed ID: 8712788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is atherosclerosis an arginine deficiency disease?
    Cooke JP
    J Investig Med; 1998 Oct; 46(8):377-80. PubMed ID: 9805422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide and the proliferation of vascular smooth muscle cells.
    Jeremy JY; Rowe D; Emsley AM; Newby AC
    Cardiovasc Res; 1999 Aug; 43(3):580-94. PubMed ID: 10690330
    [No Abstract]   [Full Text] [Related]  

  • 10. Nitric oxide in atherosclerosis: vascular protector or villain?
    Dusting GJ; Fennessy P; Yin ZL; Gurevich V
    Clin Exp Pharmacol Physiol Suppl; 1998 Nov; 25():S34-41. PubMed ID: 9809190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrahydrobiopterin and endothelial function.
    Cosentino F; Lüscher TF
    Eur Heart J; 1998 Jul; 19 Suppl G():G3-8. PubMed ID: 9717048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of nitric oxide in ischaemia/reperfusion injury of isolated hearts from severely atherosclerotic mice.
    Tokuno S; Thorèn P; Löwbeer C; Valen G
    Life Sci; 2001 Sep; 69(17):2067-80. PubMed ID: 11589521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans.
    Williams IL; Wheatcroft SB; Shah AM; Kearney MT
    Int J Obes Relat Metab Disord; 2002 Jun; 26(6):754-64. PubMed ID: 12037644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough.
    Wiest R; Groszmann RJ
    Hepatology; 2002 Feb; 35(2):478-91. PubMed ID: 11826425
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholesterol-dependent regulation of nitric oxide production: potential role in atherosclerosis.
    Coppinger RJ; Baum CL
    Nutr Rev; 1999 Sep; 57(9 Pt 1):279-82. PubMed ID: 10568338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of nitric oxide to reactive hyperemia: impact of endothelial dysfunction.
    Dakak N; Husain S; Mulcahy D; Andrews NP; Panza JA; Waclawiw M; Schenke W; Quyyumi AA
    Hypertension; 1998 Jul; 32(1):9-15. PubMed ID: 9674631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The L-arginine-nitric oxide system: physiology, physiopathology and clinical relevance].
    Garini G; Savazzi G; Borghetti A
    Recenti Prog Med; 1997 Feb; 88(2):90-9. PubMed ID: 9148375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
    Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
    Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunction of endothelial nitric oxide synthase and atherosclerosis.
    Kawashima S; Yokoyama M
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):998-1005. PubMed ID: 15001455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of endogenous nitric oxide synthase in experimental acute pancreatitis: role of anti-ICAM-1 and oxygen free radical scavengers.
    Rau B; Bauer A; Wang A; Gansauge F; Weidenbach H; Nevalainen T; Poch B; Beger HG; Nussler AK
    Ann Surg; 2001 Feb; 233(2):195-203. PubMed ID: 11176125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.